Showing results (91-100 of 123) with videos related to
Sort By:
Pageof 13
Gastroenterology|December 13, 2000
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study GroupR N Fedorak, A Gangl, C O Elson, et al.Alimentary Pharmacology & Therapeutics|November 19, 2016
Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trialB G Feagan, H Patel, J-F Colombel, et al.The New England Journal of Medicine|October 9, 1997
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study GroupS R Targan, S B Hanauer, S J van Deventer, et al.Gastroenterology|October 26, 2001
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trialW J Sandborn, S B Hanauer, S Katz, et al.AJR. American Journal of Roentgenology|October 8, 1998
CT colonography with three-dimensional problem solving for detection of colonic polypsA H Dachman, J K Kuniyoshi, C M Boyle, et al.Inflammatory Bowel Diseases|March 4, 2000
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998C Gasche, J Scholmerich, J Brynskov, et al.Alimentary Pharmacology & Therapeutics|February 23, 2018
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study)A B Friedman, S J Brown, P Bampton, et al.Human Molecular Genetics|May 18, 2000
Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel diseaseJ H Cho, D L Nicolae, R Ramos, et al.Gut|February 15, 2007
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trialW J Sandborn, S B Hanauer, P Rutgeerts, et al.Gastroenterology|December 13, 2000
Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severityS R Brant, C I Panhuysen, J E Bailey-Wilson, et al.Pageof 13